Chau CH et al. Antibody-drug conjugates for cancer. Lancet 2019;394(10200):793-804. Abstract

de Goeij BE, Lambert JM. New developments for antibody-drug conjugate-based therapeutic approaches. Curr Opin Immunol 2016;40:14-23. Abstract

Iamele L et al. Antibody–drug conjugates: Targeted weapons against cancer. Antib Technol J 2015;5:1-13. Abstract

Lin H-P et al. Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs. Br J Pharmacol 2018;175(18):3640-55. Abstract

Peng H et al. Autophagy and macropinocytosis: Keeping an eye on the corneal/limbal epithelia. Invest Ophthalmol Vis Sci 2017;58(1):416-23. Abstract

Tsuda M et al. Abnormal corneal lesions induced by trastuzumab emtansine: An antibody-drug conjugate for breast cancer. Cornea 2016;35(10):1378-80. Abstract

Zhao H et al. Modulation of macropinocytosis-mediated internalization decreases ocular toxicity of antibody-drug conjugates. Cancer Res 2018;78(8):2115-26. Abstract